• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

2017_ABR_Teaser

Download 2017 Valneva Annual Business Report

August 2, 2018  

Valneva Delivers Strong IXIARO® Sales Growth and Reports Further Progress on Key R&D Programs in H1

Read more    

— Stock information

@valnevase




















-
— July 2, 2018
Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate

Read more 
— Financial Calendar

November 8, 2018
Q3 Results 2018



See all dates






AKTUELLES

News in German


 
VALNEVA
LIBRARY


Images, presentations and videos

JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences



October 8-9
European Large & Midcap Event, Paris

October 11-13
Biotech made in Vienna: "From Landsteiner to global products for infectious disease control"
6th Semmering symposium, Vienna

October 29-31
World Vaccine Congress Europe, Lisbon

November 13-14
Stifel 2018 Healthcare Conference, New York
 
Please update your browser...